Get the Stockscreener App
81.37
0.87%
0.70
After Hours:
81.55
0.18
+0.22%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $81.37, with a volume of 6.75M.
It is up +0.87% in the last 24 hours and up +10.74% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$80.67
Open:
$80.73
24h Volume:
6.75M
Relative Volume:
0.89
Market Cap:
$103.20B
Revenue:
$386.46B
Net Income/Loss:
$4.49B
P/E Ratio:
22.70
EPS:
3.5841
Net Cash Flow:
$4.78B
1W Performance:
+6.03%
1M Performance:
+10.74%
6M Performance:
+18.70%
1Y Performance:
+25.15%
1-Day Range:
$80.63
$81.91
1-Week Range:
$77.37
$81.93
52-Week Range:
$43.56
$81.93
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
81.37 | 101.03B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
356.67 | 325.98B | 422.82B | 22.09B | 25.27B | 23.09 |
|
ELV
Elevance Health Inc
|
348.18 | 78.92B | 189.25B | 5.35B | 5.34B | 23.49 |
|
CI
Cigna Group
|
291.07 | 80.65B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
267.28 | 31.46B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare - Insider Monkey
CVS to Enhance Accessibility to Affordable Fertility Treatments - GuruFocus
84% Gonal‑F price cut — CVS Health joins TrumpRx Fertility to expand access; pickup at 9,000 stores Jan 2026 - Stock Titan
CVS Pharmacy completes acquisition of select Rite Aid, Bartell Drugs assets - Supermarket News
Step Into the Shadows, and Take a Peek at My Purloined Portfolio - TradingView
Successful pilot program addressing maternal mortality to expand in North Carolina - CVS Health
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings? - Yahoo Finance
CVS polishes off deal to buy former Rite Aid stores, prescription files - 6abc Philadelphia
Here's Why CVS Health (CVS) is a Strong Momentum Stock - Yahoo Finance
Are Medical Stocks Lagging CVS Health (CVS) This Year? - Yahoo Finance
Zacks.com featured highlights include StoneCo, PagSeguro Digital, KT, Arrow Electronics and CVS Health - Nasdaq
Zacks.com featured highlights include Hasbro, Peloton Interactive, Carvana, CVS Health and Kinross Gold - Yahoo Finance
Cantor Fitzgerald Reaffirms Overweight Rating on CVS Health (CVS) - Insider Monkey
CVS takes over Rite Aid assets in bankruptcy deal - Yahoo
Shoppers trust pharmacists and want one-on-one care: report - Supermarket News
CVS finalises purchase of Rite Aid stores and assets - Yahoo Finance
CVS is closing hundreds of stores nationwide: Here’s where - AOL.com
The Pharmacy Stock That's Cheaper Than It Should Be - AOL.com
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
CVS completes acquisition of 63 Rite Aid stores, 626 prescription files - Investing.com
CVS Acquires Rite Aid Assets to Expand Nationwide Presence - GuruFocus
CVS Health price target raised to $89 from $82 at Morgan Stanley - Yahoo Finance
63 former Rite Aid & Bartell stores: CVS completes acquisition, now serving more than 9 million former patients - Stock Titan
CVS Health EVP Capozzi buys shares worth $4588 By Investing.com - Investing.com South Africa
Ambulatory Infusion Center Market Growth Driven by Rising - openPR.com
CVS Health EVP Capozzi buys shares worth $4588 - Investing.com
How to build a custom watchlist for CVS Health CorporationJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
CVS Health (CVS) Sees Analyst Raise Price Target to $89 | CVS St - GuruFocus
Goldman Sachs Initiates Coverage on CVS Health with a Buy Rating | CVS Stock News - GuruFocus
Jim Cramer Admits He Was Wrong About CVS Health’s (CVS) Aetna - Yahoo Finance
77% of adults trust pharmacists — CVS Health 2025 Rx Report: 80% prefer in-person care; tech aids teams - Stock Titan
CVS Health Corporation $CVS Shares Sold by Community Bank N.A. - MarketBeat
Why CVS Health Corporation is moving todayMarket Trend Report & Verified Stock Trade Ideas - newser.com
CVS Health (NYSE:CVS) Hits New 52-Week HighShould You Buy? - MarketBeat
Recent Cases Spotlight Retention Lessons for AI Content from Video Recordings - JD Supra
Cvs Health Corp stock hits 52-week high at 79.21 USD - Investing.com Canada
Is now a turning point for CVS Health CorporationCEO Change & Short-Term High Return Ideas - newser.com
CVS Launches Workforce Innovation and Talent Center and Community Resource Center in Fort Worth - Yahoo Finance
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock? - Yahoo Finance
Concord Asset Management LLC VA Buys Shares of 34,078 CVS Health Corporation $CVS - MarketBeat
Yousif Capital Management LLC Has $15.60 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pzena Investment Management LLC Sells 935,521 Shares of CVS Health Corporation $CVS - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 21,544 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Tops US Medicare Quality Ratings For 2026 - Finimize
Is CVS Health Corporation stock in correction or buying zoneJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Using Bollinger Bands to evaluate CVS Health Corporation2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Rep. Val T. Hoyle Sells CVS Health Corporation (NYSE:CVS) Shares - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Means Investment CO. Inc. - MarketBeat
GFS Advisors LLC Has $248,000 Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Aberdeen Group plc - MarketBeat
US Bancorp DE Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
1.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):